CHLORPROMAZINE IN THE TREATMENT OF MENTAL ILLNESS. IV: FINAL RESULTS WITH ANALYSIS OF DATA ON 1,523 PATIENTS

Abstract

1. Of 1, 523 patients treated with chlorpromazine from 1-15 months, 81.8% showed improvement. 2. Problems concerning dose, side-effects, and clinical results have been considered. 3. Female patients used higher doses, had a proportionately larger number of sideeffects, and showed a better discharge rate than males. 4. Some theoretical considerations of these findings have been reviewed.